CDEK
← All drugs Report issue

genolimzumab

mAbexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Mar 27, 2017 (NCT03053466)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • genolimzumab

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03053466Phase 1Mar 27, 2017Apollomics, Inc., Novotech
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Apollomics, Inc.For profit1112017
NovotechFor profit1012017
2 organizations
Page 1 / 1